Literature DB >> 16952891

How successful is errorless learning in supporting memory for high and low-level knowledge in dementia?

Catherine Haslam1, Donna Gilroy, Sarah Black, Thomas Beesley.   

Abstract

Errorless learning has been shown to be very successful in the rehabilitation of memory problems particularly in patients with severe forms of memory impairment. Much of this research has focused on testing knowledge of specific details studied, ignoring any additional, higher-level knowledge that patients may have acquired during the learning process. Hence, it is pertinent to ask whether errorless learning is equally successful in the acquisition of high and low-level knowledge. In this paper, we present results of several studies comparing the effectiveness of errorless and standard trial-and-error methods in acquisition of high and low-level knowledge in people diagnosed with dementia and non-impaired controls. In Study 1, participants were asked to learn novel face-name-occupation associations; and knowledge across a range of levels, from very general (i.e., high-level) to very specific (i.e., low-level), was examined. For patients with probable Alzheimer's disease and controls there was evidence of increased benefit from errorless training in general, but the technique was most beneficial for patients attempting to retrieve specific detail. Study 2 was conducted to address the problem raised by the failure in Study 1 to manipulate learning condition at our highest knowledge level. This novel manipulation was successful, but neither of the patients received the standard benefit from errorless training. Study 3, involving a small group of dementia patients with mixed diagnoses, was conducted to replicate findings from Study 1. Results from the group analysis confirmed that the benefit obtained from errorless learning increased as a function of knowledge specificity, but again several patients failed to show a consistent effect of learning condition. Implications for use of the errorless technique are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16952891     DOI: 10.1080/09602010500231867

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  7 in total

1.  Errorless practice as a possible adjuvant to donepezil in Alzheimer's disease.

Authors:  Leslie J Gonzalez Rothi; Renee Fuller; Susan A Leon; Diane Kendall; Anna Moore; Samuel S Wu; Bruce Crosson; Kenneth M Heilman; Stephen E Nadeau
Journal:  J Int Neuropsychol Soc       Date:  2009-03       Impact factor: 2.892

Review 2.  Errorless learning in the rehabilitation of memory impairment: a critical review.

Authors:  Linda Clare; Robert S P Jones
Journal:  Neuropsychol Rev       Date:  2008-02-05       Impact factor: 7.444

Review 3.  Errorless learning of everyday tasks in people with dementia.

Authors:  Maartje M E de Werd; Daniëlle Boelen; Marcel G M Olde Rikkert; Roy P C Kessels
Journal:  Clin Interv Aging       Date:  2013-09-13       Impact factor: 4.458

4.  Functional network activity during errorless and trial-and-error color-name association learning.

Authors:  Madoka Yamashita; Tetsuya Shimokawa; Ferdinand Peper; Rumi Tanemura
Journal:  Brain Behav       Date:  2020-06-18       Impact factor: 2.708

5.  Spaced Retrieval and Episodic Memory Training in Alzheimer's Disease.

Authors:  Jeff A Small; Diana Cochrane
Journal:  Clin Interv Aging       Date:  2020-04-17       Impact factor: 4.458

6.  Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer's disease in Hong Kong: a pilot study.

Authors:  Grace Y Lee; Calvin C K Yip; Edwin C S Yu; David W K Man
Journal:  Clin Interv Aging       Date:  2013-06-07       Impact factor: 4.458

Review 7.  Treatment of Alzheimer's disease in Brazil: I. Cognitive disorders.

Authors:  Francisco de Assis Carvalho do Vale; Ylmar Corrêa Neto; Paulo Henrique Ferreira Bertolucci; João Carlos Barbosa Machado; Delson José da Silva; Nasser Allam; Márcio Luiz Figueredo Balthazar
Journal:  Dement Neuropsychol       Date:  2011 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.